Top Sell
| Security | Buy | Sell | Buy (1W) ▲ | Sell (1W) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Omeros Corp. | 2 | 4 | 0 | 0 | €3.08 | - | - |
| Coherus Bioscien. | 2 | 2 | 0 | 0 | €1.77 | €3.00 | 69.924% |
| NanoVibronix Inc. | 0 | 1 | 0 | 0 | €0.67 | - | - |
| Trevena Inc. | 2 | 14 | 0 | 0 | €0.36 | €6.48 | 1720.787% |
| Chimerix Inc. | 3 | 1 | 0 | 0 | €0.86 | €5.51 | 539.745% |
| Sage Therapeutics Inc. | 5 | 3 | 0 | 0 | €11.20 | €26.71 | 138.525% |
| Bluebird Bio Inc. | 4 | 6 | 0 | 0 | €0.90 | €6.49 | 619.173% |
| T2 Biosystems Inc. | 0 | 10 | 0 | 0 | €0.16 | - | - |
| Synthetic Biologics Inc. | 0 | 1 | 0 | 0 | €0.28 | - | - |
| Arca Biopharma | 0 | 21 | 0 | 0 | €3.20 | - | - |
| Enzo Biochem. Inc. | 0 | 1 | 0 | 0 | €0.95 | - | - |
| Acadia Pharmaceuticals | 28 | 1 | 0 | 0 | €14.03 | €31.78 | 126.625% |
| Avinger Inc. | 2 | 7 | 0 | 0 | €0.34 | €4.64 | 1272.633% |
| Bristol-Myers Squibb | 11 | 3 | 0 | 0 | €38.34 | €67.64 | 76.442% |
| InVivo Therapeutics Holdings | 1 | 17 | 0 | 0 | €0.34 | €1.60 | 370.588% |
| Pacific Biosciences of California Inc. | 10 | 5 | 0 | 0 | €1.70 | €10.20 | 500.206% |
| Palisade Bio Inc. | 3 | 1 | 0 | 0 | €0.34 | €21.06 | 6072.333% |
| Neogen Corp. | 1 | 1 | 0 | 0 | €12.10 | €20.08 | 65.982% |
| Teladoc Health Inc | 11 | 1 | 0 | 0 | €10.55 | €23.12 | 119.141% |
| Cytomx Therapeutics Inc | 1 | 1 | 0 | 0 | €1.62 | €50.00 | 2990.235% |
| Integra LifeSciences Holdings Corp | 3 | 3 | 0 | 0 | €25.60 | €34.68 | 35.463% |
| Anavex Life Sciences Corp | 0 | 2 | 0 | 0 | €3.80 | - | - |
| Moleculin Biotech Inc | 3 | 25 | 0 | 0 | €0.41 | €18.42 | 4393.659% |
| CEL-SCI Corp. | 0 | 6 | 0 | 0 | €1.16 | - | - |
| Aspira Womens Health Inc. | 0 | 1 | 0 | 0 | €2.02 | - | - |